|
|
|
|
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Baltimore, Baltimore Maryland (W.G., H.W., J.B.W.); and Herbert Irving Comprehensive Cancer Center, College of Physician and Surgeons, Columbia University, New York, New York (T.S., I.B.W.)
The human µ-opioid receptor (HµOR) is a G-protein coupled receptor that mediates analgesia, euphoria and other important central and peripheral neurological functions. In this study, we found in a yeast two-hybrid screen that a protein kinase C-interacting protein (PKCI) specifically interacts with the C terminus of HµOR. The interaction of PKCI with HµOR was recapitulated in Chinese hamster ovary cells that express the full-length HµOR and PKCI proteins. The affinity of HµOR for an opioid ligand and its ability to mediate the activation of a G-protein were not altered by their interaction. However, the association of PKCI with HµOR reduced agonist-induced inhibition of adenylyl cyclase and suppressed HµOR desensitization partially at the G protein level and completely at the adenylyl cyclase level. Furthermore, PMA-induced, but not DAMGO-induced, HµOR phosphorylation was partially inhibited by the coexpression of PKCI, suggesting that PKCI exerts a selective regulatory effect on HµOR signaling. This effect was specific to the µ-opioid receptor because
-opioid receptor desensitization was unaffected by PKCI. In addition, behavioral studies revealed that both basal and morphine-induced analgesia were significantly enhanced in the mutant mice that lacked expression of PKCI gene, and these mice developed a greater extent of tolerance to morphine analgesia. Taken together, these results suggest that PKCI functions as a negative regulator in HµOR desensitization, phosphorylation, and in mediating morphine analgesia.
Address correspondence to: Jia Bei Wang, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Baltimore, 20 N Pine Street, Baltimore MD 21201. E-mail: jwang{at}rx.umaryland.edu
This article has been cited by other articles:
![]() |
B. Cen, H. Li, and I. B. Weinstein Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src J. Biol. Chem., February 20, 2009; 284(8): 5265 - 5276. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, A. S. Balajee, T. Su, B. Cen, T. K. Hei, and I. B. Weinstein The HINT1 tumor suppressor regulates both {gamma}-H2AX and ATM in response to DNA damage J. Cell Biol., October 20, 2008; 183(2): 253 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-F. Wu, T. Koch, Y.-J. Liang, R. Stumm, S. Schulz, H. Schroder, and V. Hollt Membrane Glycoprotein M6a Interacts with the {micro}-Opioid Receptor and Facilitates Receptor Endocytosis and Recycling J. Biol. Chem., July 27, 2007; 282(30): 22239 - 22247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, Y. Zhang, H. Li, Z. Xu, R. M. Santella, and I. B. Weinstein Hint1 Inhibits Growth and Activator Protein-1 Activity in Human Colon Cancer Cells Cancer Res., May 15, 2007; 67(10): 4700 - 4708. [Abstract] [Full Text] [PDF] |
||||